We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+8.67%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$23B
AUM Growth
+$1.22B
(+5.6%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
22.7%
Holding
1,905
New
81
Increased
568
Reduced
855
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pool Corp
POOL
|
+$43.2M |
| 2 |
Atlassian
TEAM
|
+$36.6M |
| 3 |
Novanta
NOVT
|
+$28.8M |
| 4 |
Palo Alto Networks
PANW
|
+$23.2M |
| 5 |
Motorola Solutions
MSI
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$103M |
| 2 |
PayPal
PYPL
|
+$28.4M |
| 3 |
Walt Disney
DIS
|
+$26.7M |
| 4 |
CarMax
KMX
|
+$25.2M |
| 5 |
Salesforce
CRM
|
+$24.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.31% |
| 2 | Healthcare | 19.82% |
| 3 | Financials | 12.49% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Axsome Therapeutics
AXSM
$11.2B
| $721K | ﹤0.01% |
9,350
-1,440
| -13% | -$86.1K |
|
927
HUB Group
HUBG
$2.55B
| $720K | ﹤0.01% |
18,110
| – | – |
|
928
LiveRamp
RAMP
$2.31B
| $719K | ﹤0.01% |
30,667
-15,265
| -33% | -$308K |
|
929
Encore Capital Group
ECPG
$2.15B
| $717K | ﹤0.01% |
14,962
| – | – |
|
930
Vanguard Consumer Discretionary ETF
VCR
$6.11B
| $716K | ﹤0.01% |
3,271
+1,055
| +48% | +$247K |
|
931
United Airlines
UAL
$41B
| $716K | ﹤0.01% |
18,981
-1,483
| -7% | -$60.2K |
|
932
Franco-Nevada
FNV
$44.7B
| $711K | ﹤0.01% |
5,211
-605
| -10% | -$79.9K |
|
|
RDFN
933
DELISTED
Redfin
RDFN
| $709K | ﹤0.01% |
167,287
-94,659
| -36% | -$445K |
|
934
Public Service Enterprise Group
PEG
$37.8B
| $708K | ﹤0.01% |
11,560
-1,534
| -12% | -$89K |
|
935
iShares MSCI ACWI ETF
ACWI
$33.6B
| $708K | ﹤0.01% |
8,341
-409
| -5% | -$34.4K |
|
936
Viper Energy
VNOM
$14.8B
| $703K | ﹤0.01% |
22,100
+1,300
| +6% | +$42K |
|
|
AYX
937
DELISTED
Alteryx Inc
AYX
| $699K | ﹤0.01% |
13,790
-14,445
| -51% | -$689K |
|
|
FL
938
DELISTED
Foot Locker
FL
| $693K | ﹤0.01% |
+18,346
| New | +$629K |
|
939
Evergy
EVRG
$19.3B
| $689K | ﹤0.01% |
10,945
-1,415
| -11% | -$85K |
|
940
iShares US Healthcare ETF
IYH
$3.77B
| $686K | ﹤0.01% |
12,095
-100
| -0.8% | -$5.52K |
|
941
Donaldson
DCI
$11.1B
| $686K | ﹤0.01% |
11,647
-17
| -0.1% | -$974 |
|
942
MarketAxess Holdings
MKTX
$5.72B
| $684K | ﹤0.01% |
2,452
+84
| +4% | +$21.6K |
|
943
Ligand Pharmaceuticals
LGND
$5.76B
| $683K | ﹤0.01% |
10,231
-6,169
| -38% | -$401K |
|
944
Occidental Petroleum
OXY
$57.7B
| $677K | ﹤0.01% |
10,741
-510
| -5% | -$34.7K |
|
945
National Grid
NGG
$81.6B
| $674K | ﹤0.01% |
11,850
-1,769
| -13% | -$94.6K |
|
946
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $673K | ﹤0.01% |
15,734
+3,165
| +25% | +$130K |
|
947
Teledyne Technologies
TDY
$31.2B
| $670K | ﹤0.01% |
1,675
-833
| -33% | -$324K |
|
948
Sprott Physical Silver Trust
PSLV
$13.3B
| $668K | ﹤0.01% |
81,100
+1,550
| +2% | +$11.3K |
|
949
Bright Horizons
BFAM
$3.85B
| $663K | ﹤0.01% |
10,509
-718
| -6% | -$47K |
|
950
uniQure
QURE
$3.26B
| $663K | ﹤0.01% |
+29,229
| New | +$631K |
|
Similar funds
HF
William Blair & Company's Q4 2022 Portfolio in Review
As of Q4 2022, William Blair & Company held 1,905 positions worth $23B, up 5.6% from $21.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
William Blair & Company's Q4 2022 filing shows 81 new, 568 increased, 855 reduced and 91 closed positions. Its largest new stake was Atlassian: 230,078 shares worth $29.6M. The largest sale was Abiomed Inc, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q4 2022 buy was Atlassian: 230,078 shares worth $29.6M.
- William Blair & Company added most to Pool Corp in Q4 2022, an estimated $43.2M increase.
- William Blair & Company's biggest Q4 2022 reduction was PayPal, cutting an estimated $28.4M.
- William Blair & Company fully exited Abiomed Inc in Q4 2022, selling an estimated $103M.
- William Blair & Company's ten largest holdings make up 23% of its $23B portfolio in Q4 2022.
- William Blair & Company opened 81 new positions and closed 91 in Q4 2022.
- William Blair & Company's portfolio value rose 5.6% quarter-over-quarter to $23B.
Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.